Analysen von Matthew Weston

29.01.25 Sartorius Stedim Biotech Neutral UBS AG
29.01.25 Sartorius vz. Neutral UBS AG
28.01.25 Sartorius vz. Neutral UBS AG
28.01.25 Roche Neutral UBS AG
27.01.25 Novartis Buy UBS AG
24.01.25 Sartorius Stedim Biotech Neutral UBS AG
23.01.25 Sartorius vz. Neutral UBS AG
21.11.24 Novartis Buy UBS AG
20.11.24 AstraZeneca Neutral UBS AG
15.11.24 Merck Buy UBS AG
14.11.24 Novartis Buy UBS AG
14.11.24 Merck Buy UBS AG
13.11.24 Roche Neutral UBS AG
12.11.24 AstraZeneca Sell UBS AG
07.11.24 AstraZeneca Sell UBS AG
05.11.24 AstraZeneca Sell UBS AG
05.11.24 AstraZeneca Sell UBS AG
30.10.24 Roche Neutral UBS AG
30.10.24 Novartis Buy UBS AG
29.10.24 Novartis Buy UBS AG
23.10.24 Roche Neutral UBS AG
23.10.24 Merck Buy UBS AG
22.10.24 Sartorius Stedim Biotech Neutral UBS AG
22.10.24 Sartorius vz. Neutral UBS AG
17.10.24 Sartorius vz. Neutral UBS AG
17.10.24 Merck Buy UBS AG
03.10.24 Sartorius Stedim Biotech Neutral UBS AG
03.10.24 Sartorius vz. Neutral UBS AG
16.09.24 Roche Neutral UBS AG
16.09.24 AstraZeneca Sell UBS AG
13.09.24 Merck Buy UBS AG
11.09.24 Novartis Buy UBS AG
10.09.24 Roche Neutral UBS AG
09.09.24 Roche Neutral UBS AG
09.09.24 AstraZeneca Sell UBS AG
15.08.24 AstraZeneca Sell UBS AG
13.08.24 AstraZeneca Sell UBS AG
06.08.24 Merck Buy UBS AG
01.08.24 Merck Buy UBS AG
29.07.24 Merck Buy UBS AG
26.07.24 Roche Neutral UBS AG
26.07.24 AstraZeneca Sell UBS AG
19.07.24 Novartis Buy UBS AG
19.07.24 Sartorius vz. Neutral UBS AG
10.07.24 Roche Neutral UBS AG
10.07.24 Merck Buy UBS AG
10.07.24 Sartorius vz. Neutral UBS AG
09.07.24 Roche Neutral UBS AG
04.07.24 Roche Neutral UBS AG
02.07.24 Sartorius vz. Neutral UBS AG